A doctor-led medication review that applies the same clinical reasoning used to start a drug — to decide whether to continue, reduce, or stop it.
Deprescribing is not simply stopping tablets. It is a structured review of indication, benefit, risk, alternatives, monitoring, and follow-up. Medication changes should always be coordinated with your usual doctor where appropriate.
Clinical appointments via CQC-registered Sutton Medical Consulting
Follow-up support from £125
People accumulate medications during stressful years — illness, weight gain, poor sleep, menopause, a difficult season — and then never get a clean reassessment once things improve.
The GP who added the medication has moved on. The specialist who initiated it discharged you. The repeat prescription just keeps printing.
This review exists for the patient who wants one doctor to look at the whole picture.
Deprescribing is the careful reduction or stopping of medications that may no longer be helping — or may now be causing more harm than benefit.
It is not anti-medicine. It is medicine done properly.
When a medication is started, a clinical decision is made: the benefit outweighs the risk for this patient, now. That calculation changes over time. Weight changes. Blood pressure changes. Lifestyle changes. A medication started under one set of circumstances may no longer be indicated under different ones.
The review asks the same question that should have been asked at every repeat: is this still the right decision for this patient today?
"Sometimes the outcome is continue — with reassurance and a clear reason. Sometimes it is adjust, reduce, or stop — with a plan and monitoring. The decision is always personalised and safety-led."
— Dr Dan Reardon · NHS A&E Doctor · GMC 6098984Deprescribing is the planned, supervised reduction or stopping of medications that may no longer be appropriate. It is the clinical counterpart to prescribing — applying the same risk-benefit analysis that was used to start a drug, to decide whether it should continue.
Most medications are started during a specific clinical moment: a diagnosis, an acute episode, a period of poor health. The decision to start is usually well-reasoned. The problem is that the review rarely happens. Weight changes. Blood pressure normalises. The original indication resolves. The prescription continues on a repeat, unchanged, sometimes for years.
Deprescribing does not mean stopping everything. Often the outcome is to continue — with reassurance and a documented clinical reason. But when a medication's benefit no longer outweighs its risk, or when it has never been formally reviewed since it was started, the clinical duty is to question it.
In the UK, deprescribing is supported by NICE guidance, the King's Fund polypharmacy review, and NHS England's structured medication review framework. It is mainstream clinical practice — it is simply not available at the pace or depth that patients deserve in a standard GP appointment.
Each pathway has a different rebound pattern and taper strategy. Not sure which applies? A medication list review covers the full picture.
Exit planning, appetite rebound management, and long-term weight maintenance after GLP-1 treatment.
View pathway →Careful taper planning with stability scaffolding across sleep, stress load, and relapse prevention.
Book a review →Rebound reflux planning, dietary trigger identification, and step-down strategies.
Book a review →Primary prevention decisions — benefits, trade-offs, risk stratification, and the clinical case for continuing or stopping.
Book a review →Step-down with home monitoring after meaningful lifestyle improvement. Safe, monitored, and responsive.
Book a review →Do you really need it
Was the original indication clinically justified, is a question very few patients have ever been invited to ask.
View pathway →Polypharmacy
On multiple medications? One coherent, clinician-led plan — mapping the full regimen, interactions, and priorities.
View pathway →Medication changes are individual. They require review, planning, monitoring, and follow-up. This is what that looks like.
History, current medications, relevant results, side effects, and what has changed since the prescription was first written.
Is the medication still indicated? What is the risk-benefit balance now? What does stopping, reducing, or continuing actually mean for you specifically?
A personalised taper plan — gradual, responsive, with clear monitoring points and decision rules for what to do if symptoms change.
Liaison with your GP or specialist where appropriate. Follow-up available to review whether the plan is holding as expected.
Medication changes should never be made abruptly without clinical supervision. Every plan is built around safety first.
Not a recommendation to look things up. A written, personalised, medically defensible plan.
Continue, adjust, reduce, or stop — with the clinical reasoning documented clearly.
Where deprescribing is appropriate — a specific, stepwise schedule with timeframes and decision points.
What to watch for, at what intervals, and what would justify changing the plan.
What to expect and what to do if withdrawal or rebound symptoms emerge.
A written summary to your GP where appropriate, keeping your care coordinated.
Clear markers for review and a pathway back if something changes.
"My job is to review the whole picture, then build a safe step-down plan you can actually follow."
Book a Medication ReviewMost private clinics are set up to prescribe. This one is set up to review. The commercial incentive points in a different direction — and that matters when the question is whether to stop a medication, not start one.
Dr Dan Reardon is an NHS A&E doctor. Frontline emergency medicine gives a particular view of what happens downstream when medication management goes wrong — polypharmacy, missed indications, undertreated withdrawal. That experience shapes every review.
Not ideological. Not anti-medication. Clinically serious about getting the decision right.
Fees include advance review of your history and medication list, clinical interpretation, and a clear written plan.
Full medication review, step-down plan where appropriate, monitoring strategy, and written plan to take away.
Progress review, results, plan refinement, and next-step decisions.
Medication adjustments or smaller changes to an existing plan.
For a comprehensive independent review of a full medication list — including a structured written clinical report — see the Independent Medication Review £1,200 → · View all fees →
Investigation costs are separate. Where further testing is indicated, the review will identify exactly which tests are needed and the most appropriate route — NHS, GP referral, or private lab.
Evidence-led guides on stopping specific medications — what happens, when to worry, and what a proper plan looks like.
Coming Off Mounjaro: What to Expect When Stopping Tirzepatide
Coming Off Wegovy & Ozempic: What to Expect When Stopping Semaglutide
Book a medication review and leave with a clear, clinician-led plan for what to continue, adjust, or stop.
Clinical appointments via CQC-registered Sutton Medical Consulting · Sutton Coldfield